| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd473c1d33a537d8b706af0912dd0234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_415abab38f46056edefc6c4696f8c270 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate |
1994-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b2936ee5ff4e3fd1f2de7a16637829f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d124c0c135421efc311b6c1a0c32c324 |
| publicationDate |
1994-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9427610-A1 |
| titleOfInvention |
Agents containing a compound with an anti-androgen effect and a compound with a competitive, progesterone-antagonistic effect |
| abstract |
Agents contain at least one compound with an anti-androgen effect (AA) as well as at least one compound with a competitive, progesterone-antagonistic effect (PA). These agents are suitable for preparing medicaments for the prophylaxis and therapy of prostate carcinome and benign prostate hyperplasia (BPH). Also disclosed is the use of at least one compound with a PA effect to prepare medicaments for the prophylaxis and therapy of BPH. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02094379-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9965228-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03043630-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9965228-A2 |
| priorityDate |
1993-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |